Bharat Biotech s Covaxin gets nod by SEC for phase 2, 3 trials on 2 to 18 yrs
![]() |
|||
Bharat Biotech s Covaxin gets nod by SEC for phase 2, 3 trials on 2 to 18 yrs Show more
Bharat Biotech s Covaxin gets nod by SEC for phase 2, 3 trials on 2 to 18 yrs Show less
Embed: Hide
Comments